Researchers are looking into how uric acid in the blood might help figure out who is at risk for osteoporosis after menopause. Osteoporosis is a big deal because it makes bones weak and more likely to break. Right now, doctors don't have a super easy way to predict who will get it. They want to make a simple tool to help spot osteoporosis early. This could be a game...
Multiple myeloma is a serious blood cancer. It often starts from a condition called MGUS. MGUS is usually harmless. But sometimes, it can turn into multiple myeloma. Researchers wanted to find out why this happens. They looked at data from many people. They found that certain health conditions can increase the risk. These conditions include things like high blood pr...
Chronic myeloid leukemia (CML) patients face a tough question after hitting remission: what's next? Doctors often lack clear guidelines for managing care at this stage. A recent study tackles this issue by creating a model to predict the risk of relapse. The model focuses on early changes in BCR::ABL1 biomarker levels and how well patients stick to their treatment pl...
Breast cancer survivors often face a tough road ahead, even after treatment. The challenges they encounter can seriously affect their daily lives. To tackle this issue, researchers have created tools to spot patients who might face long-term problems. But how do you share this information with patients? And how do you help them manage these risks? These were the ques...
Predicting patient outcomes has always been a big deal in healthcare. It helps doctors decide how to treat patients and helps hospitals manage resources. But healthcare is always changing. So, the tools used to make these predictions need to keep up. The COVID-19 pandemic showed just how important it is to have up-to-date prediction models. These models help doctors...
Depression is not a one-size-fits-all condition. It affects people in different ways and has a high chance of coming back. Understanding how symptoms interact can help in managing this risk. A recent study looked into how connected symptoms are in people with depression and how this relates to the likelihood of relapse. Researchers tracked 87 individuals who...
In the realm of health research, scientists have been hunting for better ways to foresee type 2 diabetes. They are looking into something called proteomic biomarkers. These are tiny pieces of proteins that can hint at what's going on inside the body. The goal is to see if these biomarkers can boost the accuracy of existing risk assessments. The Cambridge Diabetes Ri...
Breast cancer tops the list of common cancers among women worldwide, with about two million new cases each year. To catch it early and save lives, many countries have set up regular breast cancer screening programs based on age. Now, experts are excited about using risk-adjusted screening, which considers more than just age. This study checked out how good risk predi...
You might think adding genetic information to clinical data can boost how well we predict health risks. But guess what? Tests show it can lead to different results. Scientists wrapped their heads around this by mixing clinical and genetic data from patient records. They wanted to figure out which decisions matter the most for the models' performance. It turns out th...
``Transplants can save lives, but they also bring risks. One big worry is posttransplant diabetes mellitus (PTDM), a type of diabetes that can happen after a liver transplant. A study looked at over 10 years of data from the Organ Procurement and Transplantation Network (OPTN) to figure out why some regions in the US have more cases of PTDM than others. They found th...